LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/New Biomaterial May Better Control Implant Degradation
Large Joints and Extremities

New Biomaterial May Better Control Implant Degradation

January 27, 2021 1 min read Premium comments

Advertisement

New Biomaterial May Better Control Implant Degradation
Source: Unsplash and Terry Vlisidis
#implants#softtissuerepair#tornligaments

A team of American and British researchers have discovered a way to fine-tune a new biomaterial to control degradation and certain mechanical properties without loss of strength.

In a new study, “Concomitant control of mechanical properties and degradation in resorbable elastomer-like materials using stereochemistry and stoichiometry for soft tissue engineering,” published in Nature Communications, the researchers show how the addition of varying amounts of succinic acid can be used to control the rate the material degrades within the body without the material losing strength.

A team at the University of Birmingham in the United Kingdom and Duke University in the United States designed the thermoplastic elastomer-like material for use in soft tissue repair. It has many applications including treating torn ligaments and other sports-related injuries.

The researchers found that it degrades gradually over a period of four months until eventually healthy tissue replaces the implant. They tested the material’s biocompatibility and safety in rat models.

The team explained that the structural changes needed to increase degradation of a biomaterial would normally weaken the material, but they were able to tweak the materials’ mechanical properties so there would be no loss strength.

This adaptability is a game changer they said.

“Biological tissues are complex with varying elastic properties. Efforts to produce synthetic replacements that have the right physical characteristics and that can also degrade in the body have been ongoing for decades,” said study co-author Andrew Dove, Ph.D., professor of sustainable polymer chemistry at the University of Birmingham.

“Part of the challenge is that a ‘one-size fits-all’ approach doesn’t work. Our research opens up the possibility of engineering biological implants with properties that can be fine-tuned for each specific application.”

“The materials we have developed offer a real advance in the ongoing search for new biomaterials. The tunable nature of the material makes it suitable for a range of different applications from replacement bone to vascular stents to wearable electronics. Additional work to prove the biocompatibility of the material and its use in more advanced demonstration is ongoing,” added Matthew Becker, Ph.D., Hugo L. Blomquist Distinguished Professor of Chemistry at Duke University.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy